LU5237
Model Information:
h/o non-small cell lung cancer metastatic adenocarcinoma, mpd. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. 20% necrosis. approximately 60% malignant tumor cells present in cytospin preparation.
| Summary |
|
| Cancer Type |
Lung Cancer |
| Grade |
NA |
| Stage |
NA |
| Ethnicity |
Western |
| Gender |
F |
| Age |
62 |
| Pathology Diagnosis |
h/o non-small cell lung cancer metastatic adenocarcinoma, mpd. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. 20% necrosis. approximately 60% malignant tumor cells present in cytospin preparation. |
| Biopsy Site |
Lt pectoral |
| Treatment History |
Carboplatin, Taxol, Gemzar, Zometa |
| Pathology QC |
Poorly differentiated adenocarcinoma with massive necrosis (P0), mucinous adenocarcinoma (P4, P7) |
| Special Features |
NA |
| Mouse Strain |
NOD SCID |
| TMA |
TMA-HP-LU-210 |
| Viral Status in PDX |
NA |
| Available In |
CB_SD, CB_CN |
| RNA Seq |
P1 |
| Exome Seq |
NA |
Growth Characteristics
Additional Characteristics
